Carcinoma of the Cervix (Cervical Cancer)
Worldwide, cervical carcinoma is the second most common cancer among women. This cancer and
the precancerous changes of the cervix are now largely viewed as a spectrum of sexually
transmitted diseases given the initiating role of the venereally transmitted Human Papillomavirus (HPV)
identified in over 90% of cases worldwide.
Cervix Cancer Test - Papanicoalau
A Cost-Effective Screening Device
While the Papanicolaou test has been confirmed as a
cost-effective screening device, it is underutilized in non-industrialized countries, as well as in the
In the United States, cervical cancer incidence and mortality has reduced by 70% due to
pap smears, but cervical cancer remains the sixth leading cause of cancer death, trailing lung, breast, colorectal, ovarian,
and endometrial malignancies.
German DR, India
Japan, England, France
42 per 105 women
From Mohar, Cancer Invest.,18(6), 2000
The incidence among Caucasian US women plateaus in the third decade at about 10/100,000, and remains at
the same rate throughout life. Among Hispanic US women, it increases with age up to 40 per 105 women into
the seventh decade before it plateaus, with an average of 30 per 105 women.
For more cervical cancer information, contact your AOA physician 972.276.9902.
Download the rest of this discussion about cervical cancer »
This PDF covers all of this material:
Carcinoma of the Cervix
- Human Papilloma Virus and Other Risk Factors
- Prevention and Risk Modification
- Symptoms of Invasive Cancer
- Diagnosis of Cancer
- Pathophysiology of Cancer
- Cancer Staging
- FIGO Stage Ia1 – lesions under 3mm
- Stages Ia2, Ib1 and IIa
- Stages Ib2
- Stages IIb to IVa
- Stage IVb
- Recurrent Disease
- Cervical Carcinoma During Pregnancy
Practical Summary of 2005 ACOG Practice Bulletin:
Management of Abnormal Cervical Cytology and Histology
Please Note: To read or print the PDF document you need Adobe® Reader®. A free program is available here; the download information will appear in a new Web browser window.